Publications en collaboration avec des chercheurs de Instituto Aragonés de Ciencias de la Salud (48)

2024

  1. APOE and familial hypercholesterolemia

    Current Opinion in Lipidology, Vol. 35, Núm. 4, pp. 195-199

  2. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

  3. Polyphenols and metabolism: from present knowledge to future challenges

    Journal of Physiology and Biochemistry, Vol. 80, Núm. 3, pp. 603-625

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Contribution of APOE Genetic Variants to Dyslipidemia

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 43, Núm. 6, pp. 1066-1077

  3. Corrigendum to “Dissecting the genetic heterogeneity of gastric cancer” (eBioMedicine (2023) 92, (S2352396423001810), (10.1016/j.ebiom.2023.104616))

    eBioMedicine

  4. Dissecting the genetic heterogeneity of gastric cancer

    eBioMedicine, Vol. 92

  5. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA (The journal of nutrition, health & aging, (2017), 21, 1, (92-104), 10.1007/s12603-016-0803-1)

    Journal of Nutrition, Health and Aging

  6. MALDI-TOF MS as a tick identification tool in a tertiary hospital in Spain

    Acta Tropica, Vol. 242

2022

  1. Indications and hemoglobin thresholds for red blood cell transfusion and iron replacement in adults with gastrointestinal bleeding: An algorithm proposed by gastroenterologists and patient blood management experts

    Frontiers in Medicine, Vol. 9

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  3. PBM: Now more than ever necessary

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 69, Núm. 6, pp. 351-354

2021

  1. Diagnostic yield of sequencing familial hypercholesterolemia genes in individuals with primary hypercholesterolemia

    Revista Espanola de Cardiologia, Vol. 74, Núm. 8, pp. 664-673

  2. Evaluation of patient involvement strategies in health technology assessment in Spain: the viewpoint of HTA researchers

    International Journal of Technology Assessment in Health Care, Vol. 37, Núm. 1

  3. Postlaunch evidence-generation studies for medical devices in Spain: the RedETS approach to integrate real-world evidence into decision making

    International Journal of Technology Assessment in Health Care, Vol. 37, Núm. 1

  4. Preoperative hemogram as a predictive factor for iron deficit and/or transfusion in patients scheduled for arthroplasty

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 68, Núm. 10, pp. 555-563

2020

  1. Efficacy and safety of the combination of pravastatin and sorafenib for the treatment of advanced hepatocellular carcinoma (Estahep clinical trial)

    Cancers, Vol. 12, Núm. 7, pp. 1-14

  2. Elevated Extracellular Free-Water in a Multicentric First-Episode Psychosis Sample, Decrease During the First 2 Years of Illness

    Schizophrenia bulletin, Vol. 46, Núm. 4, pp. 846-856

  3. Neuromuscular blockade management and postoperative outcomes in enhanced recovery colorectal surgery: Secondary analysis of POWER trial

    Minerva Anestesiologica, Vol. 87, Núm. 1, pp. 13-25

  4. The value of the continuous genotyping of multi-drug resistant tuberculosis over 20 years in Spain

    Scientific Reports, Vol. 10, Núm. 1